Insider · CIK 0001936799
Michael John Sumner
Files at INO (INOVIO PHARMACEUTICALS, INC.). First filing -, latest -.
In brief
Michael John Sumner files SEC Form 4 as officer at INO (INOVIO PHARMACEUTICALS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Michael John Sumner has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 31 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 20, 2026 | INO INOVIO PHARMACEUTICALS, INC. | MOption exercise Common Stock | +9,450 | - | - | 44,731 | May 21, 2026 |
| May 20, 2026 | INO INOVIO PHARMACEUTICALS, INC. | FTax withholding Common Stock | -2,693 | $1.23 | $3,312 | 42,038 | May 21, 2026 |
| May 20, 2026 | INO INOVIO PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitderivative | -9,450 | $0.00 | $0 | 18,900 | May 21, 2026 |
| May 20, 2026 | INO INOVIO PHARMACEUTICALS, INC. | AGrant or award Common Stock Optionderivative | +46,876 | $0.00 | $0 | 46,876 | May 21, 2026 |
| May 20, 2026 | INO INOVIO PHARMACEUTICALS, INC. | AGrant or award Restricted Stock Unitderivative | +37,684 | $0.00 | $0 | 37,684 | May 21, 2026 |
| May 15, 2026 | INO INOVIO PHARMACEUTICALS, INC. | MOption exercise Common Stock | +2,385 | - | - | 35,961 | May 18, 2026 |
| May 15, 2026 | INO INOVIO PHARMACEUTICALS, INC. | FTax withholding Common Stock | -680 | $1.30 | $884 | 35,281 | May 18, 2026 |
| May 15, 2026 | INO INOVIO PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitderivative | -2,385 | $0.00 | $0 | 0 | May 18, 2026 |
| Mar 31, 2026 | INO INOVIO PHARMACEUTICALS, INC. | MOption exercise Common Stock | +4,292 | - | - | 34,799 | Apr 1, 2026 |
| Mar 31, 2026 | INO INOVIO PHARMACEUTICALS, INC. | FTax withholding Common Stock | -1,223 | $1.74 | $2,128 | 33,576 | Apr 1, 2026 |
| Mar 31, 2026 | INO INOVIO PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitderivative | -4,292 | $0.00 | $0 | 0 | Apr 1, 2026 |
| Mar 4, 2026 | INO INOVIO PHARMACEUTICALS, INC. | AGrant or award Common Stock Optionderivative | +36,832 | $0.00 | $0 | 36,832 | Mar 5, 2026 |
| Mar 4, 2026 | INO INOVIO PHARMACEUTICALS, INC. | AGrant or award Restricted Stock Unitderivative | +29,608 | $0.00 | $0 | 29,608 | Mar 5, 2026 |
| Feb 26, 2026 | INO INOVIO PHARMACEUTICALS, INC. | MOption exercise Common Stock | +5,010 | - | - | 22,860 | Feb 27, 2026 |
| Feb 26, 2026 | INO INOVIO PHARMACEUTICALS, INC. | MOption exercise Common Stock | +11,550 | - | - | 34,410 | Feb 27, 2026 |
| Feb 26, 2026 | INO INOVIO PHARMACEUTICALS, INC. | FTax withholding Common Stock | -3,903 | $1.79 | $6,986 | 30,507 | Feb 27, 2026 |
| Feb 26, 2026 | INO INOVIO PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitderivative | -5,010 | $0.00 | $0 | 5,009 | Feb 27, 2026 |
| Feb 26, 2026 | INO INOVIO PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitderivative | -11,550 | $0.00 | $0 | 23,100 | Feb 27, 2026 |
| Jun 30, 2025 | INO INOVIO PHARMACEUTICALS, INC. | MOption exercise Common Stock | +2,916 | - | - | 17,850 | Jul 1, 2025 |
| Jun 30, 2025 | INO INOVIO PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitderivative | -2,916 | $0.00 | $0 | 0 | Jul 1, 2025 |
| May 20, 2025 | INO INOVIO PHARMACEUTICALS, INC. | AGrant or award Restricted Stock Unitderivative | +28,350 | $0.00 | $0 | 28,350 | May 21, 2025 |
| May 20, 2025 | INO INOVIO PHARMACEUTICALS, INC. | AGrant or award Common Stock Optionderivative | +35,100 | $0.00 | $0 | 35,100 | May 21, 2025 |
| May 15, 2025 | INO INOVIO PHARMACEUTICALS, INC. | MOption exercise Common Stock | +2,385 | - | - | 15,614 | May 16, 2025 |
| May 15, 2025 | INO INOVIO PHARMACEUTICALS, INC. | FTax withholding Common Stock | -680 | $1.95 | $1,326 | 14,934 | May 16, 2025 |
| May 15, 2025 | INO INOVIO PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitderivative | -2,385 | $0.00 | $0 | 2,385 | May 16, 2025 |
| Feb 26, 2025 | INO INOVIO PHARMACEUTICALS, INC. | MOption exercise Common Stock | +5,010 | - | - | 13,229 | Feb 28, 2025 |
| Feb 26, 2025 | INO INOVIO PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitderivative | -5,010 | $0.00 | $0 | 10,019 | Feb 28, 2025 |
| Feb 27, 2025 | INO INOVIO PHARMACEUTICALS, INC. | AGrant or award Common Stock Optionderivative | +42,900 | $0.00 | $0 | 42,900 | Feb 28, 2025 |
| Feb 27, 2025 | INO INOVIO PHARMACEUTICALS, INC. | AGrant or award Restricted Stock Unitderivative | +34,650 | $0.00 | $0 | 34,650 | Feb 28, 2025 |
| Dec 18, 2024 | INO INOVIO PHARMACEUTICALS, INC. | AGrant or award Common Stock Optionderivative | +5,708 | $0.00 | $0 | 5,708 | Dec 18, 2024 |
| Dec 18, 2024 | INO INOVIO PHARMACEUTICALS, INC. | AGrant or award Restricted Stock Unitderivative | +4,292 | $0.00 | $0 | 4,292 | Dec 18, 2024 |
Questions about Michael John Sumner
Answered from the filings on this page, as of the latest one.
Is Michael John Sumner buying or selling?
Michael John Sumner has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Michael John Sumner's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael John Sumner has 0.
Where does Michael John Sumner file Form 4?
Michael John Sumner has filed Form 4 at INO (INOVIO PHARMACEUTICALS, INC.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.